Editorial

Digitizing Human Beings & Personalized Medicine

Guk-Hee Suh, MD, PhD Editor-in-Chief, JoHTA; Professor, Hallym University School of Medicine, Korea J Health Tech Assess 2014;2(1):1-5

Guest Editorial

Current Issues in Pharmacoeconomic Modeling

Joel W. Hay, PhD Professor, Pharmaceutical Economics and Policy, Schaeffer Center for Health Policy and Economics, University of Southern California, USA J Health Tech Assess 2014;2(1):6-9

Original Article

Awareness of Medical Academic Societies, Consumer Organizations and Others Including Special Interest Groups and Institutes in Healthcare Sector Concerning the Pay-for-Performance in Korea

Hyeon-Jeong Lee, MPH1, Jin Yong Lee, PhD2, Sang-il Lee, PhD1, Woo-Seung Son, MPH1, Minsu Ock, MPH1, and Min-Woo Jo, PhD1 1Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, Korea 2Public Health Medical Service, Seoul National University Boramae Medical Center, Seoul, Korea J Health Tech Assess 2014;2(1):10-18

Citizen Participation in the Healthcare Decision-Making Process: Review of Real Cases

Hae Sun Suh, PhD1,2 and Boram Lee, MPH2,3 1College of Pharmacy, Pusan National University, Busan, Korea 2Research and Development Center, Health Insurance Review & Assessment Service, Seoul, Korea 3Graduate School of Public Health, Seoul National University, Seoul J Health Tech Assess 2014;2(1):19-25

Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension in Korea

Young-Joo Kim, MS1, Su-Kyoung Ko, MPH, PhD1, and Cheol-Whan Lee, MD2 1Pfizer Pharmaceuticals Korea Ltd., Seoul, Korea 2Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea J Health Tech Assess 2014;2(1):26-34

Methods on Improvement of Accessibility for Rare Disease Treatments: Providers’ Perspective

Ji Yeon Lee1, Yeong Mi Cho1, Sung Tae Kim2, and Sung Ju Kim1 1Regulatory Affairs & Market Access, Genzyme Korea, Seoul, Korea 2KIM & CHANG, Seoul, Korea J Health Tech Assess 2014;2(1):35-42

Review Article

Comparative Study on Budget Impact Analysis Guideline of Canada, Poland, Belgium and Ireland

Seong-Ok Kim, PhD1 and Sang-Eun Choi, PhD2 1Health Insurance Policy Research Institute, National Health Insurance Service, Seoul, Korea 2College of Pharmacy, Korea University, Sejong, Korea J Health Tech Assess 2014;2(1):53-63

Diagnostic Tests for Anaplastic Lymphoma Kinase Gene Rearrangement in Non-Small-Cell Lung Cancer

HyunJoo Oh, PhD1 and Dawoon Kim2 1Department of Health Policy & Administration, Inje University, Gimhae, Korea 2Medical School, Chonnam University, Gwangju, Korea J Health Tech Assess 2014;2(1):64-67

Decision Making Based on Incremental Cost-Effectiveness Ratio for Anticancer Drugs

Hoe Sang Kim, MS1, Young-Ju Kang, MS2, Su-Kyung Ko, PhD3, and Hye-Young Kang, PhD4 1Jongno-gu Public Health Center, Seoul, Korea 2The Korean Research-Based Pharmaceutical Industry Association, Seoul, Korea 3Pfizer Korea, Seoul, Korea 4College of Pharmacy, Yonsei Research Institute of Pharmaceu J Health Tech Assess 2014;2(1):68-73

Research Agenda Setting Processes in the US and UK Health Technology Assessment Institutions

Min-Jeong Kim, PhD, Shinhee Kang, PhD, and Chong Yon Park, PhD National Evidence-based Healthcare Collaborating Agency, Seoul, Korea J Health Tech Assess 2014;2(1):43-52

Case Report

Case Report of Platelet-Rich Plasma in Patients with Bone Graft at Implant Surgery

WonBae Cho1 and HyunJoo Oh, PhD2 1Kyung Won Dental Clinic, Seoul, Korea 2Department of Health Policy & Administration, Inje University, Gimhae, Korea Health Tech Assess 2014;2(1):74-77